• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Watson Pharmaceuticals, Inc. (WPI) - Financial and Strategic SWOT Analysis Review Product Image

Watson Pharmaceuticals, Inc. (WPI) - Financial and Strategic SWOT Analysis Review

  • ID: 1290960
  • April 2012
  • 42 pages
  • GlobalData

FEATURED COMPANIES

  • Cardinal Health, Inc.
  • McKesson Corporation
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sanofi-Aventis
  • MORE

Watson Pharmaceuticals, Inc. (WPI) - Financial and Strategic SWOT Analysis Review

Summary

Watson Pharmaceuticals, Inc. (Watson Pharmaceuticals) is a specialty pharmaceutical company. It carries out the development, manufacturing, marketing and distribution of specialized branded and generic pharmaceutical products. The products that the company offers are applied in the field of central nervous system, urology, women's health, hormones and synthetic substitutes, cardiovascular, nephrology, gastrointestinal and other therapeutic areas. The company's business operations can be classified into three business divisions, namely, Global Brands, Global Generics and Distribution. Geographically, through its Global Generics business, the company markets approximately 30 brand products through its Global Brands business and more than 170 generic products in the US and 350 in international markets. The company distributes approximately 8,000 stock-keeping units (SKUs) through its Anda Distribution business. Watson Pharmaceuticals is headquartered in California, the US.

The key business strategies of the company include enhanced focus on developing and distributing trusted READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cardinal Health, Inc.
  • McKesson Corporation
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sanofi-Aventis
  • MORE



List of Tables
List of Figures
Section 1 - About the Company
Watson Pharmaceuticals, Inc. - Key Facts
Watson Pharmaceuticals, Inc. - Key Employees
Watson Pharmaceuticals, Inc. - Key Employee Biographies
Watson Pharmaceuticals, Inc. - Major Products and Services
Watson Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data
Watson Pharmaceuticals, Inc., Pipeline Products by Therapy Area
Watson Pharmaceuticals, Inc., Pipeline Products by Development Phase
Watson Pharmaceuticals, Inc. - History
Watson Pharmaceuticals, Inc. - Company Statement
Watson Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Watson Pharmaceuticals, Inc. - Business Description
Watson Pharmaceuticals, Inc. - Corporate Strategy
Watson Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
Watson Pharmaceuticals, Inc. - Strengths
Strength - Sturdy Research and Development Activities
Strength - Strong Financial Performance
Strength - Broad Product Portfolio
Watson Pharmaceuticals, Inc. - Weaknesses
Weakness - Limited Customers
Watson Pharmaceuticals, Inc. - Opportunities
Opportunity - New Product Approvals and Launches
Opportunity - Growing Importance of Generics
Opportunity - New Business Initiatives
Opportunity - Growth Prospects: Emerging Markets
Watson Pharmaceuticals, Inc. - Threats
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Threat - Patent Infringement Allegation
Watson Pharmaceuticals, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Watson Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Watson Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Watson Pharmaceuticals, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Watson Pharmaceuticals, Inc., Recent Developments
Apr 03, 2012: Watson Confirms LUMIGAN And LATISSE Patent Challenges
Mar 14, 2012: Watson Confirms BYSTOLIC Patent Challenge
Feb 14, 2012: Watson Pharmaceuticals Reports Revenue Of $1.5 Billion In Q4 2011
Feb 10, 2012: Watson Confirms Beyaz's Patent Challenge
Feb 03, 2012: Watson Provides Update On Generic Lidoderm Application
Jan 30, 2012: Watson To Establish Global R&D Technology Center In New Jersey, US
Jan 26, 2012: Momenta Pharmaceuticals Motion For Preliminary Injunction Against Amphastar, Watson And International Medical Systems, Stayed
Nov 16, 2011: Watson Wins Kentucky Drug Pricing Litigation
Nov 10, 2011: Watson Confirms Appeals Court Decision Rejecting Teva's Motion To Enjoin Watson's Sales Of Generic SEASONIQUE
Nov 01, 2011: Watson Pharmaceuticals Reports Revenue Of $1.1 Billion In Q3 2011
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Watson Pharmaceuticals, Inc., Key Facts
Watson Pharmaceuticals, Inc., Key Employees
Watson Pharmaceuticals, Inc., Key Employee Biographies
Watson Pharmaceuticals, Inc., Major Products and Services
Watson Pharmaceuticals, Inc., Number of Pipeline Products by Therapy Area
Watson Pharmaceuticals, Inc., Number of Pipeline Products by Development Stage
Watson Pharmaceuticals, Inc., Pipeline Products By Therapy Area and Development Phase
Watson Pharmaceuticals, Inc., History
Watson Pharmaceuticals, Inc., Subsidiaries
Watson Pharmaceuticals, Inc., Key Competitors
Watson Pharmaceuticals, Inc., Ratios based on current share price
Watson Pharmaceuticals, Inc., Annual Ratios
Watson Pharmaceuticals, Inc., Interim Ratios
Watson Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Watson Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Watson Pharmaceuticals, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Watson Pharmaceuticals, Inc., Pipeline Products by Therapy Area
Watson Pharmaceuticals, Inc., Pipeline Products by Development Phase
Watson Pharmaceuticals, Inc., Performance Chart (2007 - 2011)
Watson Pharmaceuticals, Inc., Ratio Charts
Watson Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Watson Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012

Note: Product cover images may vary from those shown

Pfizer Inc.
Sanofi-Aventis
Teva Pharmaceutical Industries Limited
Mylan Inc.
AmerisourceBergen Corporation
Cardinal Health, Inc.
Sepracor Inc.
McKesson Corporation
Sandoz International GmbH

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos